369 related articles for article (PubMed ID: 21712032)
41. Pleiotropic activity of systemically delivered angiogenin in the SOD1
Crivello M; O'Riordan SL; Woods I; Cannon S; Halang L; Coughlan KS; Hogg MC; Lewandowski SA; Prehn JHM
Neuropharmacology; 2018 May; 133():503-511. PubMed ID: 29486168
[TBL] [Abstract][Full Text] [Related]
42. A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition.
Ibarburu S; Kovacs M; Varela V; Rodríguez-Duarte J; Ingold M; Invernizzi P; Porcal W; Arévalo AP; Perelmuter K; Bollati-Fogolín M; Escande C; López GV; King P; Si Y; Kwon Y; Batthyány C; Barbeito L; Trias E
Neurotherapeutics; 2021 Jan; 18(1):309-325. PubMed ID: 33118131
[TBL] [Abstract][Full Text] [Related]
43. Androgen receptor antagonism accelerates disease onset in the SOD1
McLeod VM; Lau CL; Chiam MDF; Rupasinghe TW; Roessner U; Djouma E; Boon WC; Turner BJ
Br J Pharmacol; 2019 Jul; 176(13):2111-2130. PubMed ID: 30849180
[TBL] [Abstract][Full Text] [Related]
44. A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model.
Post J; Kogel V; Schaffrath A; Lohmann P; Shah NJ; Langen KJ; Willbold D; Willuweit A; Kutzsche J
Molecules; 2021 Mar; 26(6):. PubMed ID: 33805709
[TBL] [Abstract][Full Text] [Related]
45. Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice.
Lapucci A; Cavone L; Buonvicino D; Felici R; Gerace E; Zwergel C; Valente S; Mai A; Chiarugi A
Neurosci Lett; 2017 Aug; 656():120-125. PubMed ID: 28732762
[TBL] [Abstract][Full Text] [Related]
46. Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis.
Wang J; Tierney L; Mann R; Lonsway T; Walker CL
Mol Brain; 2021 Oct; 14(1):155. PubMed ID: 34635126
[TBL] [Abstract][Full Text] [Related]
47. Bojungikgi-tang Improves Muscle and Spinal Cord Function in an Amyotrophic Lateral Sclerosis Model.
Cai M; Lee SH; Yang EJ
Mol Neurobiol; 2019 Apr; 56(4):2394-2407. PubMed ID: 30030751
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
[TBL] [Abstract][Full Text] [Related]
49. Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model.
Cai M; Yang EJ
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689925
[TBL] [Abstract][Full Text] [Related]
50. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
[TBL] [Abstract][Full Text] [Related]
51. EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS.
Le Pichon CE; Dominguez SL; Solanoy H; Ngu H; Lewin-Koh N; Chen M; Eastham-Anderson J; Watts R; Scearce-Levie K
PLoS One; 2013; 8(4):e62342. PubMed ID: 23638043
[TBL] [Abstract][Full Text] [Related]
52. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
[TBL] [Abstract][Full Text] [Related]
53. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
54.
Kosuge Y; Kaneko E; Nango H; Miyagishi H; Ishige K; Ito Y
Oxid Med Cell Longev; 2020; 2020():1020673. PubMed ID: 32089764
[TBL] [Abstract][Full Text] [Related]
55. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice.
Buonvicino D; Felici R; Ranieri G; Caramelli R; Lapucci A; Cavone L; Muzzi M; Di Pietro L; Bernardini C; Zwergel C; Valente S; Mai A; Chiarugi A
Neuroscience; 2018 May; 379():228-238. PubMed ID: 29588251
[TBL] [Abstract][Full Text] [Related]
56. Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1
Ruiz-Ruiz C; García-Magro N; Negredo P; Avendaño C; Bhattacharya A; Ceusters M; García AG
Dis Model Mech; 2020 Oct; 13(10):. PubMed ID: 33174532
[TBL] [Abstract][Full Text] [Related]
57. Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1
Mòdol-Caballero G; Herrando-Grabulosa M; García-Lareu B; Solanes N; Verdés S; Osta R; Francos-Quijorna I; López-Vales R; Calvo AC; Bosch A; Navarro X
Neurobiol Dis; 2020 Apr; 137():104793. PubMed ID: 32032731
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1
Weerasekera A; Sima DM; Dresselaers T; Van Huffel S; Van Damme P; Himmelreich U
Neuroimage Clin; 2018; 20():1092-1105. PubMed ID: 30368196
[TBL] [Abstract][Full Text] [Related]
59. Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Exp Neurol; 2008 Sep; 213(1):122-8. PubMed ID: 18617166
[TBL] [Abstract][Full Text] [Related]
60. Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice.
Bernard-Marissal N; Sunyach C; Marissal T; Raoul C; Pettmann B
Neurobiol Dis; 2015 Jan; 73():130-6. PubMed ID: 25277755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
